Jazz Pharmaceuticals
JAZZ
JAZZ
325 hedge funds and large institutions have $8.58B invested in Jazz Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 65 funds opening new positions, 107 increasing their positions, 118 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
9% less repeat investments, than reductions
Existing positions increased: 107 | Existing positions reduced: 118
48% less call options, than puts
Call options by funds: $137M | Put options by funds: $261M
Holders
325
Holding in Top 10
12
Calls
$137M
Puts
$261M
Top Buyers
| 1 | +$435M | |
| 2 | +$53M | |
| 3 | +$42M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$41.2M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$39.8M |
Top Sellers
| 1 | -$53M | |
| 2 | -$52.2M | |
| 3 | -$52.1M | |
| 4 |
LPC
Lone Pine Capital
Greenwich,
Connecticut
|
-$47.9M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$42.1M |